[Cardiotoxicity of mianserin, an antidepressant (author's transl)].
The effect of mianserin on cardiac function was investigated on 60 adults with known heart disease, the drug previously having been shown not to influence the action of phenprocoumon. After satisfactory anticoagulation had been established, all patients were given additionally two different dosage regimens of mianserin or a placebo in a double-blind trial lasting three weeks. The dose was gradually increased to a maximal daily level of 30 mg or 60 mg, respectively, on the sixth day. Heart rate, blood pressure and electrocardiogram were obtained before and after mianserin had been added. There was no statistically significant difference between the three trial groups with respect to the three measured variables.
D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D003984:Dibenzazepines / Q000633:toxicity*; D004311:Double-Blind Method; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000187:drug effects*; D006801:Humans; D008297:Male; D008803:Mianserin / Q000008:administration & dosage / Q000633:toxicity*; D008875:Middle Aged; D010919:Placebos; D011674:Pulse / Q000187:drug effects
D003984:Dibenzazepines; D010919:Placebos; D008803:Mianserin
Antidepressiva und Kardiotoxizität. Beobachtungen mit Mianserin.